TAXIS Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:TAXIS Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013316
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TAXIS Pharmaceuticals Inc (TAXIS Pharma) is a healthcare products company that offers drug discovery services. The company develops and discovers pharmaceuticals targeting infectious diseases. It identifies new classes of antibiotic agents use a novel mechanism of bactericidal action different from any other antibiotic in clinical use. TAXIS Pharma offers services such as research and development, chemical synthesis and laboratory services. The company’s outsources production of bulk intermediates through the US and other international suppliers. Its XA709 is used for the treatment of methicillin-resistant Staphylococcus aureus. The company’s products are used in treatment of bacterial infections, and others. TAXIS Pharma is headquartered in Monmouth Junction, New Jersey, the US.

TAXIS Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Taxis Pharma to Raise USD5 Million in Venture Financing 10
Taxis Pharma Raises USD1.2 Million in Venture Financing 11
Taxis Pharma Raises USD3 Million in Venture Financing 12
TAXIS Pharmaceuticals Inc – Key Competitors 13
TAXIS Pharmaceuticals Inc – Key Employees 14
TAXIS Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
09/07/2016: FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic: 16
Clinical Trials 17
Jun 13, 2016: Experimental Antibiotic Treats Deadly MRSA Infection 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TAXIS Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Taxis Pharma to Raise USD5 Million in Venture Financing 10
Taxis Pharma Raises USD1.2 Million in Venture Financing 11
Taxis Pharma Raises USD3 Million in Venture Financing 12
TAXIS Pharmaceuticals Inc, Key Competitors 13
TAXIS Pharmaceuticals Inc, Key Employees 14

★海外企業調査レポート[TAXIS Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Posco International Corp (047050):企業の財務・戦略的SWOT分析
    Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Synchronoss Technologies, Inc. (SNCR):企業の財務・戦略的SWOT分析
    Synchronoss Technologies, Inc. (SNCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • InFlectis BioScience:製薬・医療:M&Aディール及び事業提携情報
    Summary InFlectis BioScience (InFlectis) is a drug discovery company that identifies and develops small molecule drugs that target the unfolded protein response to treat misfolding protein disorders such as age-related and neurodegenerative diseases. The company’s pipeline products include IFB-088, …
  • IntraPace Inc-医療機器分野:企業M&A・提携分析
    Summary IntraPace Inc (IntraPace) is a medical device company that develops novel implantable systems. The company provides abiliti systems that contains sensors intended to track consumption events and physical activity using this information to direct when therapy is delivered and to monitor a pat …
  • Burmeister & Wain Scandinavian Contractor AS-エネルギー分野:企業M&A・提携分析
    Summary Burmeister & Wain Scandinavian Contractor A/S (BWSC), a subsidiary of MESCO Denmark A/S, is a provider of tailor-made turnkey power plant solutions. It develops, operates and undertakes contracts for medium to large-scale power plants. The company handles projects for conventional fossil-fue …
  • VVC Exploration Corp (VVC):企業の財務・戦略的SWOT分析
    Summary VVC Exploration Corp (VVC) is a mining and mineral exploration company. It is involved in acquisition, exploration, and development of gold, copper, silver, and other mineral properties. Its projects portfolio includes Gloria, Cumeral, La Tuna, and Timmins projects. VVC also offers open-pit …
  • Omaxe Ltd:企業の戦略・SWOT・財務情報
    Omaxe Ltd - Strategy, SWOT and Corporate Finance Report Summary Omaxe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • National Beverage Corp.:企業の戦略・SWOT・財務情報
    National Beverage Corp. - Strategy, SWOT and Corporate Finance Report Summary National Beverage Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Empire District Electric Company-エネルギー分野:企業M&A・提携分析
    Summary The Empire District Electric Company (EDE), a subsidiary of Liberty Utilities Co., is a regulated utility that provides electricity, natural gas, and water services. The company generates, procures, transmits, distributes, and sells electricity. It generates electricity from natural gas, coa …
  • Noerr LLP:企業の戦略的SWOT分析
    Noerr LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422)-製薬・医療分野:企業M&A・提携分析
    Summary Sichuan Kelun Pharmaceutical Co Ltd (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The company’s products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’ …
  • Gree Inc (3632):企業の財務・戦略的SWOT分析
    Gree Inc (3632) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Akers Biosciences Inc (AKER):企業の製品パイプライン分析2018
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Macquarie Group Ltd:企業の戦略・SWOT・財務分析
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pelican Rouge Group B.V.:企業の戦略・SWOT・財務情報
    Pelican Rouge Group B.V. - Strategy, SWOT and Corporate Finance Report Summary Pelican Rouge Group B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Manappuram Finance Limited (MANAPPURAM):企業の財務・戦略的SWOT分析
    Manappuram Finance Limited (MANAPPURAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析
    Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • 88 Energy Ltd (88E):石油・ガス:M&Aディール及び事業提携情報
    Summary 88 Energy Ltd (88 Energy), formerly Tangiers Petroleum Ltd, is an exploration and production company that develops oil-rich provinces. The company offers discovery, exploration and development of onshore oil projects. It has oil and gas assets in Morocco and Australia. 88 Energy’s Morocco pr …
  • Pampa Energia SA (PAMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Pampa Energia SA (Pampa) is an independent integrated energy company. It generates, distributes and transmits electricity; and explores and produces, refines oil and gas, and petrochemicals and commercializes and transports them. The company produces electricity using coal, wind, hydro, and …
  • Kanika Hotels Public Company Limited:企業の戦略・SWOT・財務分析
    Kanika Hotels Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Kanika Hotels Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆